In-Person Only
End users who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
CXO's, VP's, Directors and Managers Responsible For
Technical Operations
Formulation And Stability
Process Development
Intensified & Continuous Bioprocessing
Cell Therapy CMC Manufacturing
Gene Therapy Manufacturing
Gene Therapy | Cell Therapy
Biomedical Engineering
Cell Line Development
Regulatory Affairs
Cell Engineering
Supply Chain | Cold Chain
Stem Cell Manufacturing
Novel Vector Systems
Regenerative Medicine
Key Topics
Cell And Gene Therapies Commercialisation And Supply
Bringing New Therapeutic Modalities To Patients On A Global Scale
Commercialising Transformative Innovation: Lessons Learned
Trying To Be Different By Staying Inside The Box; A New CDMO Model Supporting Renewed Domestic Biomanufacturing In The US.
Streamline Scale-Up And Technology Transfer To CMOs
Execute Quality Systems Internally And Externally With Partners
Rethinking CDMO - Partnership, Selection, Negotiation, Tech Transfer, Life Cycle Management
Best Practices Of CMC Analytics For Cell And Gene Therapies
Examing Analytical Technologies And CMC Comparability Of Biotechnology Products
Discuss Data Integrity Challenges With Contract Manufacturers/CDMOs
Identifying Bioprocessing Innovations For Next-Generation Antibody-Based Modalities
Rethinking Global Supply Chain For Inventory Build And Planning
Co-Located Topics
Bio Innovation Topics 2023
Evolving And Digitising Toward Next-Generation Bioprocessing
Digital Innovation And The Rise Of Immersive Technologies At Takeda
Creating An Effective Adoption Of Single-Use Systems And Continuous Bioprocessing
Continuous Integrated Bioprocessing For ATMPs
Smart Chromatographyâ„¢ - A Method For Scalable Primary Purification, Removing The Clarification Bottlenecks
Build Flexible, Automated Multi-Product Manufacturing Facilities
Smart Process Design - AI-Enhanced Models For Cutting-Edge Process Development
Enhance Quality Metrics Readiness And Regulatory Expectations
The Future Of IMP Supplies: A Success Story
Application Of Various Models For Enhanced Process And Plant Utilisation."Digital Process Twins - Case Studies
Expanded Bed Adsorption Chromatography At Commercial Scale For Injectable Therapeutics
Innovation In Recovery And Purification
Implementation of a Digital and Online CPV Plan
Speakers 30%
End Users 60%
Buying power 90%
Vendors 10%
6th Annual CGTI Leaders Summit 2023
Advancing cell and gene therapies through strategic collaboration and technology innovation
Co-Located - 15th Annual BILS Leaders Summit
15th - 16th February 2023
Hotel Palace Berlin 5* - Germany
"The Global Cell and Gene Therapy Market is estimated to be up to $67 Billion by 2030."
The 6th Annual Cell and Gene Therapy Innovation Summit is an exclusive in-person-only gathering for up to 200 decision-makers, intellectual vanguards and captains of industry.
With more regenerative medicine products approaching clinical testing and commercialisation, seize this opportunity to hear detailed insights and industry best practices from renowned presenters.
Achieve a deeper understanding of the many manufacturing and industrialisation burdens unique to carrying durable and curative therapies to needy patients.
